Allergan Said to Seek Actavis Takeover to Spurn Valeant

The video discusses the news of Alan's private talks with activists, which could lead to an alternative deal. Bill Ackman, a key figure, is pushing for Valiant to take over Allergan, but faces opposition. Valiant's $54 billion offer is deemed inadequate by Allergan, and critics argue Valiant aims to use Allergan's cash to reduce its debt. The situation is portrayed as a potential constructive merger.

What is the significance of Alan's private talks with activists?

• It could lead to a new alternative deal.

• It is a routine business meeting.

• It is a public announcement.

• It involves a government intervention.

What role does Bill Ackman play in the potential takeover of Allergan?

• He is a competitor of Valiant.

• He is against any takeover.

• He is pushing for Valiant to take over Allergan.

• He is a neutral observer.

Why is Bill Ackman trying to remove certain directors from Allergan?

• To increase his own power.

• To change the company's name.

• To reduce company expenses.

• To support the deal with Valiant.

How does Allergan view Valiant's $54 billion offer?

• As a generous offer.

• As grossly inadequate.

• As a fair market value.

• As a hostile takeover.

What is a major criticism of Valiant's takeover strategy?

• It aims to use Allergan's cash to pay down debt.

• It focuses on innovation.

• It seeks to expand into new markets.

• It plans to increase employee benefits.